Peripheral Drug Eluting Balloons Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026-2033

Description

Persistence Market Research has recently released a comprehensive report on the global Peripheral Drug Eluting Balloons market. The report delivers an in-depth evaluation of key market dynamics-drivers, trends, opportunities, and restraints-while offering detailed insights into market structure, value chain evolution, and competitive positioning across regions.

Key Insights

Peripheral Drug Eluting Balloons Market Size (2026E): US$ 1.2 Bn
Projected Market Value (2033F): US$ 2.1 Bn
Global Market Growth Rate (CAGR 2026-2033): 8.6%

Peripheral Drug Eluting Balloons Market - Report Scope

Peripheral drug-eluting balloons are minimally invasive endovascular devices coated with antiproliferative medications to treat peripheral arterial disease and reduce restenosis. These balloons deliver drugs like paclitaxel and sirolimus to vessel walls without permanent implants. Applications include femoropopliteal, infrapopliteal, and carotid interventions, with primary use in hospitals and specialized vascular centers managing complex atherosclerotic lesions and limb-threatening ischemia.

Market Growth Drivers

Rising prevalence of peripheral arterial disease in aging and diabetic populations. Strong clinical and regulatory evidence supporting paclitaxel and sirolimus efficacy. Growing preference for minimally invasive endovascular procedures over surgery. Favorable reimbursement frameworks in key markets like U.S., Europe, and China.

Market Restraints

Lingering safety perceptions and legacy concerns around paclitaxel-coated devices. High per-procedure costs relative to plain balloon angioplasty limiting adoption. Inconsistent reimbursement mechanisms and cost pressures across regions.

Market Opportunities

Expansion of sirolimus-based peripheral balloons with improved vascular healing profiles. Growing clinical use in complex femoropopliteal, below-the-knee, and in-stent restenosis. Vessel-preparation technology integration supporting limb-preservation strategies. Emerging market penetration in Asia-Pacific through local manufacturing and approvals.

Key Questions Answered in the Report

What are the major factors driving global demand for peripheral drug eluting balloons?
Which product segments and applications are fueling Peripheral Drug Eluting Balloons market growth?
How is North America, 39% share (2025) shaping the Peripheral Drug Eluting Balloons market landscape?
Who are the leading players in the peripheral drug eluting balloons market, and what strategies are they adopting?
What are the emerging trends and long-term growth prospects for the global Peripheral Drug Eluting Balloons market?

Competitive Intelligence and Business Strategy

Leading players in the peripheral drug eluting balloons market are focusing on capacity expansion, product innovation, and strategic partnerships to strengthen their global footprint. Investments in advanced technologies and vertical integration help ensure consistent product quality and supply reliability. Companies are also prioritizing long-term customer relationships and geographic expansion, while emphasizing sustainability, operational efficiency, and cost optimization to gain a competitive edge.

Key Companies Profiled

Abbott Laboratories
Boston Scientific Corporation
Medtronic plc
Cook Medical Inc.
MicroPort Scientific Corporation
B. Braun Melsungen AG
BIOTRONIK SE & Co. KG
Becton, Dickinson and Company
W. L. Gore & Associates Inc.
Getinge AB
Terumo Corp
Surmodics Inc.
Cardinal Health Inc.
Kyoto Medical Planning Co Ltd
iVascular S.L.U

Market Segmentation

By Drug Coating

Paclitaxel Drug Coating
Sirolimus Drug Coating
Others

By Indication

Peripheral Arterial Disease
Peripheral Aneurysms
In-Stent Restenosis
Others

By Artery Type

Femoropopliteal arteries
Infrapopliteal
Carotid
Iliac

By End User

Hospitals
Ambulatory Surgical Centers
Standalone Cardiac Catheterization Labs

By Region

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP27211

1. Executive Summary

1.1. Global Peripheral Drug Eluting Balloons Market Snapshot, 2026 and 2033
1.2. Market Opportunity Assessment, 2026-2033, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Peripheral Drug Eluting Balloons Market: Value Chain
- 2.4.1. List of Raw Material Suppliers
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. Profitability Analysis
2.5. Forecast Factors - Relevance and Impact
2.6. Covid-19 Impact Assessment
2.7. PESTLE Analysis
2.8. Porter's Five Forces Analysis
2.9. Geopolitical Tensions: Market Impact
2.10. Regulatory and Application Landscape

3. Macro-Economic Factors

3.1. Global Sectorial Outlook
3.2. Global GDP Growth Outlook
3.3. Global Parent Market Overview

4. Price Trend Analysis, 2020 - 2033

4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Prices By Product Type/Composition/Application
4.4. Regional Prices and Product Preferences

5. Global Peripheral Drug Eluting Balloons Market Outlook: Historical (2020-2025) and Forecast (2026-2033)

5.1. Key Highlights
- 5.1.1. Market Size and Y-o-Y Growth
- 5.1.2. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
- 5.2.1. Historical Market Size Analysis, 2020-2025
- 5.2.2. Current Market Size Forecast, 2026-2033
5.3. Global Peripheral Drug Eluting Balloons Market Outlook: Drug Coating
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Mn) and Volume Analysis By Drug Coating, 2020-2025
- 5.3.3. Current Market Size (US$ Mn) and Volume Forecast By Drug Coating, 2026-2033
  - 5.3.3.1. Paclitaxel Drug Coating
  - 5.3.3.2. Sirolimus Drug Coating
  - 5.3.3.3. Others
5.4. Market Attractiveness Analysis: Drug Coating
5.5. Global Peripheral Drug Eluting Balloons Market Outlook: Indication
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Mn) and Volume Analysis By Indication, 2020-2025
- 5.5.3. Current Market Size (US$ Mn) and Volume Forecast By Indication, 2026-2033
  - 5.5.3.1. Peripheral Arterial Disease
  - 5.5.3.2. Peripheral Aneurysms
  - 5.5.3.3. In-Stent Restenosis
  - 5.5.3.4. Others
5.6. Market Attractiveness Analysis: Indication

6. Global Peripheral Drug Eluting Balloons Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2020-2025
6.3. Current Market Size (US$ Mn) and Volume Forecast By Region, 2026-2033
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia & Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Peripheral Drug Eluting Balloons Market Outlook: Historical (2020-2025) and Forecast (2026-2033)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
- 7.3.1. By Country
- 7.3.2. By Drug Coating
- 7.3.3. By Indication
7.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
- 7.4.1. U.S.
- 7.4.2. Canada
7.5. Current Market Size (US$ Mn) and Volume Forecast By Drug Coating, 2026-2033
- 7.5.1. Paclitaxel Drug Coating
- 7.5.2. Sirolimus Drug Coating
- 7.5.3. Others
7.6. Current Market Size (US$ Mn) and Volume Forecast By Indication, 2026-2033
- 7.6.1. Peripheral Arterial Disease
- 7.6.2. Peripheral Aneurysms
- 7.6.3. In-Stent Restenosis
- 7.6.4. Others
7.7. Market Attractiveness Analysis

8. Europe Peripheral Drug Eluting Balloons Market Outlook: Historical (2020-2025) and Forecast (2026-2033)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
- 8.3.1. By Country
- 8.3.2. By Drug Coating
- 8.3.3. By Indication
8.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. U.K.
- 8.4.4. Italy
- 8.4.5. Spain
- 8.4.6. Russia
- 8.4.7. Rest of Europe
8.5. Current Market Size (US$ Mn) and Volume Forecast By Drug Coating, 2026-2033
- 8.5.1. Paclitaxel Drug Coating
- 8.5.2. Sirolimus Drug Coating
- 8.5.3. Others
8.6. Current Market Size (US$ Mn) and Volume Forecast By Indication, 2026-2033
- 8.6.1. Peripheral Arterial Disease
- 8.6.2. Peripheral Aneurysms
- 8.6.3. In-Stent Restenosis
- 8.6.4. Others
8.7. Market Attractiveness Analysis

9. East Asia Peripheral Drug Eluting Balloons Market Outlook: Historical (2020-2025) and Forecast (2026-2033)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
- 9.3.1. By Country
- 9.3.2. By Drug Coating
- 9.3.3. By Indication
9.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. South Korea
9.5. Current Market Size (US$ Mn) and Volume Forecast By Drug Coating, 2026-2033
- 9.5.1. Paclitaxel Drug Coating
- 9.5.2. Sirolimus Drug Coating
- 9.5.3. Others
9.6. Current Market Size (US$ Mn) and Volume Forecast By Indication, 2026-2033
- 9.6.1. Peripheral Arterial Disease
- 9.6.2. Peripheral Aneurysms
- 9.6.3. In-Stent Restenosis
- 9.6.4. Others
9.7. Market Attractiveness Analysis

10. South Asia & Oceania Peripheral Drug Eluting Balloons Market Outlook: Historical (2020-2025) and Forecast (2026-2033)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
- 10.3.1. By Country
- 10.3.2. By Drug Coating
- 10.3.3. By Indication
10.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
- 10.4.1. India
- 10.4.2. Southeast Asia
- 10.4.3. ANZ
- 10.4.4. Rest of South Asia & Oceania
10.5. Current Market Size (US$ Mn) and Volume Forecast By Drug Coating, 2026-2033
- 10.5.1. Paclitaxel Drug Coating
- 10.5.2. Sirolimus Drug Coating
- 10.5.3. Others
10.6. Current Market Size (US$ Mn) and Volume Forecast By Indication, 2026-2033
- 10.6.1. Peripheral Arterial Disease
- 10.6.2. Peripheral Aneurysms
- 10.6.3. In-Stent Restenosis
- 10.6.4. Others
10.7. Market Attractiveness Analysis

11. Latin America Peripheral Drug Eluting Balloons Market Outlook: Historical (2020-2025) and Forecast (2026-2033)

11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
- 11.3.1. By Country
- 11.3.2. By Drug Coating
- 11.3.3. By Indication
11.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
- 11.4.1. Brazil
- 11.4.2. Mexico
- 11.4.3. Rest of Latin America
11.5. Current Market Size (US$ Mn) and Volume Forecast By Drug Coating, 2026-2033
- 11.5.1. Paclitaxel Drug Coating
- 11.5.2. Sirolimus Drug Coating
- 11.5.3. Others
11.6. Current Market Size (US$ Mn) and Volume Forecast By Indication, 2026-2033
- 11.6.1. Peripheral Arterial Disease
- 11.6.2. Peripheral Aneurysms
- 11.6.3. In-Stent Restenosis
- 11.6.4. Others
11.7. Market Attractiveness Analysis

12. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook: Historical (2020-2025) and Forecast (2026-2033)

12.1. Key Highlights
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
- 12.3.1. By Country
- 12.3.2. By Drug Coating
- 12.3.3. By Indication
12.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
- 12.4.1. GCC
- 12.4.2. South Africa
- 12.4.3. Northern Africa
- 12.4.4. Rest of Middle East & Africa
12.5. Current Market Size (US$ Mn) and Volume Forecast By Drug Coating, 2026-2033
- 12.5.1. Paclitaxel Drug Coating
- 12.5.2. Sirolimus Drug Coating
- 12.5.3. Others
12.6. Current Market Size (US$ Mn) and Volume Forecast By Indication, 2026-2033
- 12.6.1. Peripheral Arterial Disease
- 12.6.2. Peripheral Aneurysms
- 12.6.3. In-Stent Restenosis
- 12.6.4. Others
12.7. Market Attractiveness Analysis

13. Competition Landscape

13.1. Market Share Analysis, 2025
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.2.3. Apparent Production/Service Capacity
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Abbott Laboratories
  - 13.3.1.1. Overview
  - 13.3.1.2. Segments and Products
  - 13.3.1.3. Key Financials
  - 13.3.1.4. Market Developments
  - 13.3.1.5. Market Strategy
- 13.3.2. Boston Scientific Corporation
- 13.3.3. Medtronic plc
- 13.3.4. Cook Medical Inc.
- 13.3.5. MicroPort Scientific Corporation
- 13.3.6. B. Braun Melsungen AG
- 13.3.7. BIOTRONIK SE & Co. KG
- 13.3.8. Becton, Dickinson and Company
- 13.3.9. W. L. Gore & Associates Inc.
- 13.3.10. Getinge AB
- 13.3.11. Terumo Corp
- 13.3.12. Surmodics Inc.
- 13.3.13. Cardinal Health Inc.
- 13.3.14. Kyoto Medical Planning Co Ltd
- 13.3.15. iVascular S.L.U

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations